ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,220Medicare Part D Prescriptions Filled, Including Refills

Rank: 312 out of 783

$356K Total Retail Price of All Prescriptions

Rank: 410 out of 783

322 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,833 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCHLOROTHIAZIDE 341 331 1 12
SIMVASTATIN 300 283 2 3
LEVOTHYROXINE SODIUM 293 275 3 1
AMLODIPINE BESYLATE 281 263 4 5
LISINOPRIL 254 250 5 4
METOPROLOL SUCCINATE 199 199 6 13
SERTRALINE HCL 197 185 7 22
ATENOLOL 184 184 8 17
FUROSEMIDE 173 167 9 7
POTASSIUM CHLORIDE 157 145 10 16
HYDROCODONE-ACETAMINOPHEN 156 142 S3 11 2
OMEPRAZOLE 146 146 12 6
BENAZEPRIL HCL 133 129 13 85
WARFARIN SODIUM 130 130 14 10
PRAVASTATIN SODIUM 128 110 15 14
ATORVASTATIN CALCIUM 121 113 16 11
DONEPEZIL HCL 114 114 17 24
NIFEDIPINE ER 93 90 18 135
METOPROLOL TARTRATE 87 82 19 9
GLIMEPIRIDE 87 87 19 34
CEPHALEXIN 77 74 21 70
LEVOXYL 74 73 22 150
TAMSULOSIN HCL 71 71 23 26
PREDNISONE 70 56 24 36
ALENDRONATE SODIUM 70 70 24 25
LOSARTAN POTASSIUM 69 69 26 18
METFORMIN HCL 68 68 27 8
CHLORTHALIDONE 67 67 28 143
GABAPENTIN 67 65 28 15
DIOVAN 65 62 30 49
ZOLPIDEM TARTRATE 63 63 31 23
CLOPIDOGREL 59 57 32 29
ENALAPRIL MALEATE 55 45 33 68
FLUOXETINE HCL 54 54 34 45
TERAZOSIN HCL 53 47 35 130
NAMENDA 52 52 36 32
NIFEDICAL XL 51 51 37 364
AMITRIPTYLINE HCL 50 49 R 38 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.